Tokyo, Japan

Hideo Tanaka

USPTO Granted Patents = 68 

 

 

Average Co-Inventor Count = 2.5

ph-index = 14

Forward Citations = 711(Granted Patents)


Inventors with similar research interests:


Location History:

  • Tokushima, JP (1995 - 1997)
  • Miyagi, JP (1987 - 2000)
  • Sakado, JP (2000 - 2001)
  • Hitachi, JP (2001)
  • Saitama, JP (1992 - 2003)
  • Ohsaka-fu, JP (2010)
  • Kyoto, JP (2011)
  • Otsu, JP (2012)
  • Osaka, JP (2010 - 2015)
  • Kanagawa, JP (2010 - 2019)
  • Tokyo, JP (1984 - 2020)

Company Filing History:

goldMedal12 out of 58,129 
 
Sony Corporation
 patents
silverMedal10 out of 35,658 
 
Nec Corporation
 patents
bronzeMedal10 out of 28,544 
 
Ricoh Company, Ltd.
 patents
46 out of 845 
 
Otsuka Pharmaceutical Company, Limited
 patents
54 out of 21,351 
 
Mitsubishi Denki Kabushiki Kaisha
 patents
64 out of 129 
 
Kabushiki Kaisha Nippon Conlux
 patents
73 out of 2,861 
 
Pioneer Electronic Corporation
 patents
83 out of 773 
 
Hirose Electric Company, Ltd.
 patents
92 out of 177 
 
The Tokyo Electric Power Company, Incorporated
 patents
102 out of 10,092 
 
Honda Giken Kogyo Kabushiki Kaisha
 patents
111 out of 51 
 
Mitsubishi Materials Silicon Corporation
 patents
121 out of 2,899 
 
Seiko Instruments Inc
 patents
131 out of 314 
 
Taisho Pharmaceutical Co., Ltd.
 patents
141 out of 150 
 
Kajima Corporation
 patents
151 out of 2,630 
 
The Furukawa Electric Co., Ltd.
 patents
161 out of 341 
 
Suntory Holdings Limited
 patents
171 out of 27 
 
Solar Frontier K.k.
 patents
181 out of 278 
 
Hitachi Zosen Corporation
 patents
197 out of 832,680 
Other
 patents
where one patent can have more than one assignee

Years Active: 1984-2025

Loading Chart...
Loading Chart...
Loading Chart...
68 patents (USPTO):Explore Patents

Title: The Innovative Journey of Hideo Tanaka: A Pioneer in Antitumor Compositions and Engineering Solutions

Introduction: Hideo Tanaka, a prominent inventor based in Tokyo, Japan, has made significant contributions to the fields of medicine and engineering. With an impressive portfolio of 68 patents, his innovative spirit has led to groundbreaking advancements, particularly in antitumor compositions and fluid management systems.

Latest Patents: Tanaka's research has culminated in notable patents, including an antitumor composition that combines various antitumor agents. This composition aims to significantly shrink tumors through synergistic antitumor action without increasing side effects, showcasing a remarkable balance between efficacy and safety. The patented formulation includes compound (B) or its salts in combination with antitumor agent (A), which encompasses a range of therapeutic agents, from alkylating agents to tyrosine kinase inhibitors.

Additionally, his invention of a mixture preventing valve represents a leap in fluid dynamics technology. This valve features a well-designed structure with separate flow passages and a valve body that effectively opens and closes communication between the fluids, thereby preventing unnecessary mixing.

Career Highlights: Throughout his career, Hideo Tanaka has been associated with esteemed companies such as Sony Corporation and NEC Corporation. His work in these organizations has established him as a respected figure in both the tech and biomedical fields, where innovation is crucial.

Collaborations: Tanaka's journey has been enriched by collaborations with talented professionals like Ichiro Kuroda and Tomoyuki Takahashi. These partnerships have not only facilitated knowledge sharing but also contributed to the successful development and refinement of his patentable ideas.

Conclusion: Hideo Tanaka's legacy as an inventor is marked by his relentless pursuit of innovation and excellence. With a solid portfolio and collaborative efforts, he continues to impact the realms of medicine and engineering, paving the way for future advancements that resonate on a global scale. Through his contributions, Tanaka exemplifies the essence of innovation, inspiring countless others to pursue their inventive endeavors.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…